Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria

Journal of Hepatology

Volumn 48, Issue 2, 2008, Pages 375-379

  Kong, Xiao Fei ^a   Ye, Jing ^a   Gao, De Yong ^a   Gong, Qi Ming ^a   Zhang, Dong Hua ^a   Lu, Zhi Meng ^a   Lu, Yi Ming ^a   Zhang, Xin Xin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Erythropoietic protoporphyria; Ferrochelatase mutation; IVS3 48T C; Liver complication

Indexed keywords

FERROCHELATASE;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CODON; ERYTHROPOIETIC PROTOPORPHYRIA; FEMALE; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; HUMAN; LIVER DISEASE; MALE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHOTOSENSITIVITY; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; AGED; CHILD; FEMALE; FERROCHELATASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTOPORPHYRIA, ERYTHROPOIETIC;

EID: 37849001329     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.09.013     Document Type: Article

References (22)

1. Todd D.J. Erythropoietic protoporphyria. Br J Dermatol 131 (1994) 751-766
2. Bloomer J., Bruzzone C., Zhu L., Scarlett Y., Magness S., and Brenner D. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation. J Clin Invest 102 (1998) 107-114
3. McGuire B.M., Bonkovsky H.L., Carithers Jr. R.L., Chung R.T., Goldstein L.I., Lake J.R., et al. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 11 (2005) 1590-1596
4. Taketani S., Inazawa J., Nakahashi Y., Abe T., and Tokunaga R. Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. Eur J Biochem 205 (1992) 217-222
5. Rossi E., Costin K.A., and Garcia-Webb P. Ferrochelatase activity in human lymphocytes, as quantified by a new high-performance liquid-chromatographic method. Clin Chem 34 (1988) 2481-2485
6. Gouya L., Deybach J.C., Lamoril J., Da S.V., Beaumont C., Grandchamp B., et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 58 (1996) 292-299
7. Gouya L., Puy H., Robreau A.M., Bourgeois M., Lamoril J., Da S.V., et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 30 (2002) 27-28
8. Gouya L., Martin-Schmitt C., Robreau A.M., Austerlitz F., Da S.V., Brun P., et al. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet 78 (2006) 2-14
9. Henriksson M., Timonen K., Mustajoki P., Pihlaja H., Tenhunen R., Peltonen L., et al. Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients. J Invest Dermatol 106 (1996) 346-350
10. Rufenacht U.B., Gouya L., Schneider-Yin X., Puy H., Schafer B.W., Aquaron R., et al. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62 (1998) 1341-1352
11. Wang X., Yang L., Kurtz L., Lichtin A., DeLeo V.A., Bloomer J., et al. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene. J Invest Dermatol 113 (1999) 87-92
12. Saruwatari H., Ueki Y., Yotsumoto S., Shimada T., Fukumaru S., Kanekura T., et al. Genetic analysis of the ferrochelatase gene in eight Japanese patients from seven families with erythropoietic protoporphyria. J Dermatol 33 (2006) 603-608
13. Onaga Y., Ido A., Uto H., Hasuike S., Kusumoto K., Moriuchi A., et al. Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria. Biochem Biophys Res Commun 321 (2004) 851-858
14. Liao K.H. Cutaneous porphyrias in China. J Dermatol 18 (1991) 307-310
15. Aurizi C., Schneider-Yin X., Sorge F., Macri A., Minder E.I., and Biolcati G. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria. Mol Genet Metab 90 (2007) 402-407
16. Wiman A., Floderus Y., and Harper P. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. J Hum Genet 48 (2003) 70-76
17. Gouya L., Schneider-Yin X., Rufenacht U., Herrero C., Lecha M., Mascaro J.M., et al. Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria. J Invest Dermatol 111 (1998) 406-409
18. Kondo M., Yano Y., Shirataka M., Urata G., and Sassa S. Porphyrias in Japan: compilation of all cases reported through 2002. Int J Hematol 79 (2004) 448-456
19. Li H.Z., Zhou X.P., Zheng Y., and Li X. Case report of two patients with porphyria. Clin Misdiagn Misther 18 (2005) 438
20. Liao K.H., Zheng P.S., Wang X.S., and Hou L.D. Clinical and protoporphyria analysis of 38 patients with erythropoietic protoporphyria. Zhong Hua Pi Fu Ke Za Zhi 23 (1990) 9-11
21. Chen J.P., and Zhang P. Liver pathology of 1 patients with erythropoietic protoporphyria. Acta Univ Medicinalis Nangjing 21 (2001) 552-553
22. Magness S.T., Maeda N., and Brenner D.A. An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyria. Blood 100 (2002) 1470-1477